The role of TGF-β1, P53 and microRNA 192 in the pathogenesis of diabetic nephropathy in diabetic rats

International Journal of Clinical and Experimental Medicine

Volumn 9, Issue 2, 2016, Pages 3139-3145

  Liu, Qian ^a   Jiao, Xiumin ^b   Chen, Bixiao ^a   Zhao, Wei ^a   Meng, Dong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Diabetic nephropathy; microRNA 192; P53; TGF

Indexed keywords

MICRORNA 192; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; IMMUNOHISTOCHEMISTRY; MALE; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84962277779     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Huang P, Zhang Y, Jiang T, Zeng W, Zhang N. Role of aldose reductase in the high glucose induced expression of fibronectin in human mesangial cells. Mol Biol Rep 2010; 37: 3017-21.
2. Huang P, Zhang Y, Jiang T, Zeng W, Zhang N. Aldose reductase is a potent regulator of TGF-beta1 induced expression of fibronectin in human mesangial cells. Mol Biol Rep 2010; 37: 3097-103.
3. Elmarakby AA, Abdelsayed R, Yao Liu J, Mozaffari MS. Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. EPMA J 2010; 1: 117-29.
4. Samarakoon R, Overstreet JM, Higgins SP, Higgins PJ. TGF-beta1 --> SMAD/p53/USF2 --> PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res 2012; 347: 117-28.
5. Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond) 2013; 124: 139-52.
6. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell 2012; 148: 1172-87.
7. Zhang Y, Xiao HQ, Wang Y, Yang ZS, Dai LJ, Xu YC. Differential expression and therapeutic efficacy of microRNA-346 in diabetic nephropathy mice. Exp Ther Med 2015; 10: 106-12.
8. Koga K, Yokoi H, Mori K, Kasahara M, Kuwabara T, Imamaki H, Ishii A, Mori KP, Kato Y, Ohno S, Toda N, Saleem MA, Sugawara A, Nakao K, Yanagita M, Mukoyama M. MicroRNA-26a inhibits TGF-beta-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy. Diabetologia 2015; 58: 2169-80.
9. Castro NE, Kato M, Park JT, Natarajan R. Transforming growth factor beta1 (TGF-beta1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells. J Biol Chem 2014; 289: 29001-13.
10. Docherty NG, Murphy M, Martin F, Brennan EP, Godson C. Targeting cellular drivers and counter-regulators of hyperglycaemia- and transforming growth factor-beta1-associated profibrotic responses in diabetic kidney disease. Exp Physiol 2014; 99: 1154-62.
11. Trionfini P, Benigni A, Remuzzi G. MicroRNAs in kidney physiology and disease. Nat Rev Nephrol 2015; 11: 23-33.
12. Suzuki HI, Miyazono K. Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway. J Mol Med (Berl) 2010; 88: 1085-94.
13. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011; 208: 875-83.
14. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012; 12: 613-26.
15. Kato M, Park JT, Natarajan R. MicroRNAs and the glomerulus. Exp Cell Res 2012; 318: 993-1000.
16. Kato M, Arce L, Wang M, Putta S, Lanting L, Natarajan R. A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells. Kidney Int 2011; 80: 358-68.
17. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, Natarajan R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 2007; 104: 3432-7.
18. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol 2010; 21: 438-47.
19. Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME, Kantharidis P. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta. Diabetes 2010; 59: 1794-802.